This story is part of the Reno Gazette Journal’s essential coronavirus coverage and is provided for free. Please consider subscribing.
The first shipment of the Johnson & Johnson vaccine arrived in Washoe County Tuesday afternoon.
Approximately 3,600 doses were delivered to the Washoe County Health District, according to a press release from the Regional Information Center.
The county is working to introduce the doses in the upcoming vaccine Point of Dispensing (POD) events in the area, but no details are confirmed yet, according to the press release.
“We still have a very low supply of vaccine, and people aren’t going to have the option of which vaccine they want, but it’s really important to get vaccinated with whichever is vaccine is available,” Jim English said in a press briefing Monday.
Doses of the Johnson & Johnson vaccine, also known as Janssen, will be an addition to the thousands of Moderna and Pfizer vaccines that the county has been receiving weekly.
A total of 24,000 Janssen doses have been ordered across the state, according to health official Candice McDaniel.
Janssen is the pharmaceutical company manufacturing the vaccine and is owned by Johnson & Johnson. If a resident receives this specific vaccine, the information on the vaccine card will read “Janssen” and not “Johnson & Johnson, according to the press release.
Unlike the Moderna and Pfizer vaccines, the Janssen vaccines only requires one dose and does not need to be kept in a freezer.
But the Moderna and Pfizer-BioNTech vaccines appear to be more effective than Janssen’s, showing better than 94% effectiveness in large trials they ran last year.
The vaccines can’t be compared directly, however, because the trials were conducted at different times. Janssen’s vaccine appeared to be 72% effective among U.S. trial participants. It was less effective in South Africa and Latin America, where newer strains of the virus are circulating.
— USA TODAY’s Maureen Groppe contributed to this report.
Kristin Oh is a public safety reporter for the Reno Gazette Journal. She can be reached at email@example.com or at 775-420-1285. Please help support her work by subscribing.